FDA Warns 18 Websites Over Unapproved Botox Products After Reports of Injuries

FDA-approved Botox products carry the agency’s most serious label, which indicates a significant risk of life-threatening side effects.
FDA Warns 18 Websites Over Unapproved Botox Products After Reports of Injuries
Signage is seen outside of the FDA headquarters in White Oak, Md., on Aug. 29, 2020. Andrew Kelly/File Photo/Reuters
Bill Pan
Bill Pan
Reporter
|Updated:
0:00

Federal regulators have warned 18 websites allegedly selling counterfeit or unapproved versions of Botox and similar injectable drugs commonly used to smooth facial wrinkles.

The Food and Drug Administration (FDA) stated on Wednesday that it issued the warnings after receiving reports of injuries linked to these products, including cases of toxic side effects.